The H3 K27M mutation was confirmed by NGS, which also identified three mutations in the tyrosine kinase domain of FGFR1 (amino acids 478–767) and a mutation in PIK3CA. Over the course of 23 months, the tumor has demonstrated no evidence of regrowth, and has remained unchanged in size. This evidence concerns the gene FGFR1 and neoplasm.